SANTA MONICA, Calif., July 7, 2025 /PRNewswire/ -- Lifeforce, the world's largest longevity medicine platform, and Toku, a health technology company using AI to...
Major Highlights
Outstanding results from Dense Media Separation (DMS) and flotation test work confirm the high quality and added value of lithium at the...
The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation
MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/...
BEIJING, July 7, 2025 /PRNewswire/ -- An icon of Chinese contemporary auteur cinema, director Jia Zhangke draws public attention with every appearance. Recently in Shanghai,...
While competitors push high-THC options, Area 52’s Delta 8 Gummies lead with a balanced, clear-headed experience—now joined by UFO MAX and UFO in the top 3
While competitors push high-THC options, Area 52’s Delta 8 Gummies lead with a balanced, clear-headed experience—now joined by UFO MAX and UFO in the top 3
DALLAS, 04 juill. 2025 (GLOBE NEWSWIRE) -- La Crosetto Foundation for the Reduction of Cancer Deaths, une organisation à but non lucratif agréée, lance un « appel urgent aux membres du Parlement européen et des parlements nationaux : il faut geler les financements destinés à la phase 2 des mises à niveau des expériences ATLAS et CMS du CERN ».
DELRAY BEACH, Fla., July 4, 2025 /PRNewswire/ --
What's driving the shift from analog to intelligent auscultation?
The global digital stethoscopes market, valued at US$0.49 billion...
DELRAY BEACH, Fla., July 4, 2025 /PRNewswire/ --
What's driving the shift from analog to intelligent auscultation?
The global digital stethoscopes market, valued at US$0.49 billion...
A Groundbreaking Celebration of a New Gundam Era in Los Angeles
LOS ANGELES, July 4, 2025 /PRNewswire/ -- Yesterday, Mobile Suit Gundam GQuuuuuuX ignited the stage...
DALLAS, July 04, 2025 (GLOBE NEWSWIRE) -- Die Crosetto Foundation for the Reduction of Cancer Deaths, eine anerkannte gemeinnützige Organisation, richtet einen „dringenden Appell an die Mitglieder des Europäischen Parlaments und der nationalen Parlamente: Die Finanzierung der Phase-2-Upgrades der ATLAS- und CMS-Experimente des CERN ist auszusetzen“.